Interactions of neuromuscular blocking drugs

Acta Anaesthesiologica Belgica

Volumn 52, Issue 4, 2001, Pages 357-363

  Cammu, G ^a  

^a OLV HOSPITAL   (Belgium)

Author keywords

Anaesthesia, general; Blocking agents, neuromuscular; Drug interactions

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ATRACURIUM; BETA LACTAM ANTIBIOTIC; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; CISATRACURIUM; CORTICOSTEROID; DIMETHYLTUBOCURARINE CHLORIDE; ENFLURANE; IMMUNOSUPPRESSIVE AGENT; LINCOSAMINE DERIVATIVE; LOCAL ANESTHETIC AGENT; MIVACURIUM; NEOMYCIN; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; PHENYTOIN; PIPECURONIUM; POLYMYXIN; PROPOFOL; ROCURONIUM; SEVOFLURANE; SUXAMETHONIUM; TUBOCURARINE CHLORIDE; UNINDEXED DRUG; VECURONIUM;

ACID BASE BALANCE; ANESTHESIOLOGICAL TECHNIQUES; ANESTHETIC RECOVERY; CANCER PATIENT; CLINICAL PRACTICE; CONFERENCE PAPER; DRUG POTENTIATION; DRUG RESPONSE; GENERAL ANESTHESIA; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE; KIDNEY FAILURE; LIVER DYSFUNCTION; NEUROMUSCULAR BLOCKING; TEMPERATURE;

ANESTHETICS; ANTI-BACTERIAL AGENTS; ANTICONVULSANTS; DRUG INTERACTIONS; DRUG SYNERGISM; HUMANS; MAGNESIUM; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR BLOCKING AGENTS;

EID: 0035675572     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (98)

1. Miller R. D., Way W. L., Dolan W. M., et al., Comparative neuromuscular effects of pancuronium, gallamine, and succinylcholine during forane and halothane anesthesia in man, ANESTHESIOLOGY, 35, 509-514, 1971.
2. Fogdall R. P., Miller R. D., Neuromuscular blocking effects of enflurane, alone and combined with d-tubocurarine, pancuronium, and succinylcholine in man, ANESTHESIOLOGY, 42, 173-178, 1975.
3. Bennett M. J., Hahn J. F., Potentiation of the combination of pancuronium and metocurine by halothane and isoflurane in humans with and without renal failure, ANESTHESIOLOGY, 62, 759-764, 1985.
4. Rupp S. M., Miller R. D., Gencarelli P. J., Vecuronium-induced neuromuscular blockade during enflurane, isoflurane, and halothane anesthesia in humans, ANESTHESIOLOGY, 60, 102-105, 1984.
5. Chapple D. J., Clark J. S., Hughes R., Interaction between atracurium and drugs used in anaesthesia, BR. J. ANAESTH., 55, S17-22, 1983.
6. Kansanaho M., Olkkola K. T., The effect of halothane on mivacurium infusion requirements in adult surgical patients, ACTA ANAESTHESIOL. SCAND., 41, 754-759, 1997.
7. Suzuki T., Iwasaki K., Fukano N., et al., Duration of exposure to sevoflurane affects dose-response relationship of vecuronium, BR. J. ANAESTH., 85, 732-734, 2000.
8. Morita T., Kurosaki D., Tsukagoshi H., et al., Factors affecting neostigmine reversal of vecuronium block during sevoflurane anaesthesia, ANAESTHESIA, 52, 538-543, 1997.
9. Rupp S. M., McChristian J. W., Miller R. D., Neuromuscular effects of atracurium during halothane-nitrous oxide and enflurane-nitrous oxide anesthesia in humans, ANESTHESIOLOGY, 63, 16-19, 1985.
10. Brandom B. W., Rudd G. D., Cook D. R., Clinical pharmacology of atracurium in paediatric patients, BR. J. ANAESTH., 55, S117-121, 1983.
11. 2/propofol anesthesia, ANESTHESIOLOGY, 81, A1117, 1994.
12. Muir A. W., Anderson K. A., Pow E., Interaction between rocuronium bromide and some drugs used during anaesthesia, EUR. J. ANAESTHESIOL., 11, S93-98, 1994.
13. Agoston S., Interactions of volatile anaesthetics with rocuronium bromide in perspective, EUR. J. ANAESTHESIOL., 11, S107-111, 1994.
14. Bock M., Klippel K., Nitsche B., et al., Rocuronium potency and recovery characteristics during steady-state desflurane, sevoflurane, isoflurane or propofol anaesthesia, BR. J. ANAESTH., 84, 43-47, 2000.
15. Nakata Y., Goto T., Morita S., Vecuronium-induced neuromuscular block during xenon or sevoflurane anaesthesia in humans, BR. J. ANAESTH., 80, 238-240, 1998.
16. Cara D. M., Armory P., Mahajan R. P., Prolonged duration of neuromuscular block with rapacuronium in the presence of sevoflurane, ANESTH. ANALG., 91, 1392-1393, 2000.
17. Szalados J. E., Donati F., Bevan D. R., Nitrous oxide potentiates succinylcholine neuromuscular blockade in humans, ANESTH. ANALG., 72, 18-21, 1991.
18. Waud B. E., Waud D. R., Effects of volatile anesthetics on directly and indirectly stimulated skeletal muscle, ANESTHESIOLOGY, 50, 103-110, 1979.
19. McIndewar I. C., Marshall R. J., Interaction between the neuromuscular blocking drug ORG NC45 and some anaesthetic, analgesic and antimicrobial agents, BR. J. ANAESTH., 53, 785-792, 1981.
20. Nakayama Y., Narimatsu E., Sumita S., et al., Propofol enhances a d-tubocurarine-induced twitch depression in septic rat diaphragm, ANESTH. ANALG., 90, 80-84, 2000.
21. Matsuo S., Rao D. B., Chaudry I., et al., Interaction of muscle relaxants and local anesthetics at the neuromuscular junction, ANESTH. ANALG., 57, 580-587, 1978.
22. Hall D. R., McGibbon D. H., Evans C. C., et al., Gentamicin, tubocurarine, lignocaine and neuromuscular blockade. A case report, BR. J. ANAESTH., 44, 1329-1332, 1972.
23. Naguib M., Abdulatif M., al-Ghamdi A., et al., Interactions between mivacurium and atracurium, BR. J. ANAESTH., 73, 484-489, 1994.
24. Lebowitz P. W., Ramsey F. M., Savarese J. J., et al., Combination of pancuronium and metocurine : Neuromuscular and hemodynamic advantages over pancuronium alone, ANESTH. ANALG., 60, 12-17, 1981.
25. Okamoto T., Nakai T., Aoki T., et al., Interaction between vecuronium and pancuronium, MASUI, 42, 534-539, 1993.
26. Erkola O., Rautoma P., Meretoja O. A., Mivacurium when preceded by pancuronium becomes a long-acting muscle relaxant, ANESTHESIOLOGY, 84, 562-565, 1996.
27. Naguib M., Samarkandi A. H., Ammar A., et al., Comparative clinical pharmacology of rocuronium, cisatracurium, and their combination, ANESTHESIOLOGY, 89, 1116-1124, 1998.
28. Naguib M., Neuromuscular effects of rocuronium bromide and mivacurium chloride administered alone and in combination, ANESTHESIOLOGY, 81, 388-395, 1994.
29. Kim K. S., Chun Y. S., Chon S. U., et al., Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination, ANAESTHESIA, 53, 872-878, 1998.
30. Martyn J. A., Leibel W. S., Matteo R. S., Competitive non-specific binding does not explain the potentiating effects of muscle relaxant combinations, ANESTH. ANALG., 62, 160-163, 1983.
31. Su P. C., Su W. H., Rosen A. D., Pre-and postsynaptic effects of pancuronium at the neuromuscular junction of the mouse, ANESTHESIOLOGY, 50, 199-204, 1979.
32. Waud B. E., Waud D. R., Interaction among agents that block end-plate depolarization competitively, ANESTHESIOLOGY, 63, 4-15, 1985.
33. Feldman S. A., Fauvel N. J., Hood J. R., Recovery from pancuronium and vecuronium administered simultaneously in the isolated forearm and the effect on recovery following administration after cross-over of drugs, ANESTH. ANALG., 76, 92-95, 1993.
34. Ferguson A., Bevan D. R., Mixed neuromuscular block : the effect of precurarization, ANAESTHESIA, 36, 661-666, 1981.
35. Jones R. S., Interaction between atracurium and suxamethonium in the dog, RES. VET. SCI., 40, 299-302, 1986.
36. Stovner J., Oftedal N., Holmboe J., The inhibition of cholinesterase by pancuronium, BR. J. ANAESTH., 47, 949-954, 1975.
37. Krieg N., Hendrickx H. H., Crul J. F., Influence of suxamethonium on the potency of ORG NC45 in anaesthetized patients, BR. J. ANAESTH., 53, 259-262, 1981.
38. Pavlin E. G., Forrest A. P., Howard M., et al., Prior administration of succinylcholine does not affect the duration of nimbex (51W89) neuromuscular blockade, ANESTH. ANALG., 80, S374, 1995.
39. Roed J., Larsen P. B., Olsen J. S., et al., The effect of succinylcholine on atracurium-induced neuromuscular block, ACTA ANAESTHESIOL. SCAND., 41, 1331-1334, 1997.
40. Braga M. F., Rowan E. G., Harvey A. L., et al., Interactions between suxamethonium and non-depolarizing neuromuscular blocking drugs, BR. J. ANAESTH., 72, 198-204, 1994.
41. Fleming N. W., Macres S., Antognini J. F., et al., Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine, BR. J. ANAESTH., 77, 492-495, 1996.
42. Tryba M., Potentiation of the effect of non-depolarizing muscle relaxants by acylaminopenicillins. Studies on the example of vecuronium, ANAESTHESIST., 34, 651-655, 1985.
43. Condon R. E., Munshi C. A., Arfman R. C., Interaction of vecuronium with piperacillin or cefoxitin evaluated in a prospective, randomized, double-blind clinical trial, AM. SURG., 61, 403-406, 1995.
44. Argov Z., Mastaglia F. L., Drug therapy : disorders of neuromuscular transmission caused by drugs, N. ENGL. J. MED., 301, 409-413, 1979.
45. Mirakhur R. K., Cooper A. R., Maddineni V. R., An evaluation of the interactions of rocuronium bromide with antibiotics, EUR. J. ANAESTHESIOL., 11, S103-106, 1994.
46. Hasfurther D. L., Bailey P. L., Failure of neuromuscular blockade reversal after rocuronium in a patient who reveived oral neomycin, CAN. J. ANAESTH., 43, 617-20, 1996.
47. Hans P., Ledoux D., Bonhomme V, et al., Effect of plasma anticonvulsant level on pipecuronium-induced neuromuscular blockade : preliminary results, J. NEUROSURG. ANESTHESIOL., 7, 254-258, 1995.
48. Platt P. R., Thackray N. M., Phenytoin-induced resistance to vecuronium, ANAESTH. INTENSIVE CARE, 21, 185-191, 1993.
49. Driessen J. J., Robertson E. N., Booij L. H., et al., Accelerated recovery and disposition from rocuronium in an end-stage renal failure patient on chronic anticonvulsant therapy with sodium valproate and primidone, BR. J. ANAESTH., 80, 386-388, 1998.
50. Spacek A., Neiger F. X., Krenn C. G., et al., Rocuronium-induced neuromuscular block is affected by chronic carbazepine therapy, ANESTHESIOLOGY, 90, 109-112, 1999.
51. Soriano S. G., Kaus S. J., Sullivan L. J., et al., Onset and duration of action of rocuronium in children receiving chronic anticonvulsant therapy, PAEDIATR. ANAESTH., 10, 133-136, 2000.
52. Hickey D. R., Sangwan S., Bevan J. C., Phenytoin-induced resistance to pancuronium. Use of atracurium infusion in management of a neurosurgical patient, ANAESTHESIA, 43, 757-759, 1988.
53. Tempelhoff R., Modica P. A., Jellish W. S., et al., Resistance to atracurium-induced neuromuscular blockade in patients with intractable seizure disorders treated with anticonvulsants, ANESTH. ANALG., 71, 665-669, 1990.
54. Spacek A., Neiger F. X., Spiss C. K., et al., Atracurinm-induced neuromuscular block is not affected by chronic anticonvulsant therapy with carbamazepine, ACTA ANAESTHESIOL. SCAND., 41, 1308-1311, 1997.
55. Ornstein E., Matteo R. S., Silverberg P. A., et al., Dose-response relationships for vecuronium in the presence of chronic phenytoin therapy, ANESTH. ANALG., 65, S116, 1986.
56. Ornstein E., Schwartz A. E., Matteo R. S., et al., Predictability of atracurium effect in phenytoin exposed patients, ANESTHESIOLOGY, 65, A112, 1986.
57. Melton A. T., Antognini J. F., Gronert G. A., Prolonged duration of succinylcholine in patients receiving anticonvulsants : evidence for mild up-regulation of acetylcholine receptors ?, CAN. J. ANAESTH., 40, 939-942, 1993.
58. Saarnivaara L., Ertama P., Interactions between lithium/ rubidium and six muscle relaxants. A study on the rat phrenic nerve-hemidiaphragm preparation, ANAESTHESIST., 41, 760-764, 1992.
59. Spacek A., Nickl S., Neiger F. X., et al., Augmentation of the rocuronium-induced neuromuscular block by the acutely administered phenytoin, ANESTHESIOLOGY, 90, 1551-1555, 1999.
60. Talke P. O., Caldwell J. E., Richardson C. A., et al., The effects of dexmedetomidine on neuromuscular blockade in human volunteers, ANESTH. ANALG., 88, 633-639, 1999.
61. Sekerci S., Tulunay M., Interactions of calcium channel blockers with non-depolarising muscle relaxants in vitro, ANAESTHESIA, 51, 140-144, 1996.
62. Wali F A., Verapamil intensifies neuromuscular blockade produced by gallamine and pancuronium at the chick neuromuscular junction, PHARMACOL. RES. COMMUN., 18, 529-541, 1986.
63. Wali F. A., Interactions of nifedipine and diltiazem with muscle relaxants and reversal of neuromuscular blockade with edrophonium and neostigmine, J. PHARMACOL., 17, 244-253, 1986.
64. Singh Y. N., Johnson A., Lulf L. A., et al., Study of in vitro effects of isradipine in skeletal muscles and interaction with some drugs, METHODS FIND. EXP. CLIN. PHARMACOL., 18, 499-506, 1996.
65. Kim K. S., Kim K. H., Shin W. J., et al., Neuromuscular interactions between mivacurium and esmolol in rabbits, ANAESTHESIA, 53, 140-145, 1998.
66. Kindler C. H., Verotta D., Gray A. T., et al., Additive inhibition of nicotinic acetylcholine receptors by corticosteroids and the neuromuscular blocking drug vecuronium, ANESTHESIOLOGY, 92, 821-832, 2000.
67. Crosby E., Robblee J. A., Cyclosporine-pancuronium interaction in a patient with a renal allograft, CAN. J. ANAESTH., 35, 300-302, 1988.
68. 2 antagonists and non-depolarizing muscle relaxants, ANAESTHESIST, 38, 251-254, 1989.
69. Ahmed S. M., Panja C., Khan R. M., et al., Lansoprazole potentiates vecuronium paralysis, J. INDIAN MED. ASSOC., 95, 422-423, 1997.
70. Narimatsu E., Nakayama Y., Aimono M., et al., Milrinone, a phosphodiesterase III inhibitor, antagonizes the neuromuscular blocking effect of a non-depolarizing muscle relaxant in vitro, RES. COMMUN. MOL. PATHOL. PHARMACOL., 104, 219-228, 1999.
71. Ibebunjo C., Donati F., Fox G. S., et al., The effects of chronic tacrine therapy on d-tubocurarine blockade in the soleus and tibialis muscles of the rat, ANESTH. ANALG., 85, 431-436, 1997.
72. Saitoh Y., Fujii Y., Oshima T., The ulinastatin-induced effect on neuromuscular block caused by vecuronium, ANESTH. ANALG., 89, 1565-1569, 1999.
73. Latorre F., de Almeida M. C., Stanek A., et al., The interaction between rocuronium and smoking. The effect of smoking on neuromuscular transmission after rocuronium, ANAESTHESIST, 46, 493-495, 1997.
74. Weathermon R., Crabb D. W., Alcohol and medication interactions, ALCOHOL RES. HEALTH, 23, 40-54, 1999.
75. Fuchs-Buder T., Ziegenfuss T., Lysakowski K., et al., Antagonism of vecuronium-induced neuromuscular block in patients pretreated with magnesium sulphate : dose-effect relationship of neostigmine, BR. J. ANAESTH., 82, 61-65, 1999.
76. Ahn E. K., Bai S. J., Cho B. J., et al., The infusion rate of mivacurium and its spontaneous neuromuscular recovery in magnesium-treated parturients, ANESTH. ANALG., 86, 523-526, 1998.
77. Guay J., Grenier Y., Varin F., Clinicalpharmacokinetics of neuromuscular relaxants in pregnancy, CLIN. PHARMACOKINET, 34, 483, 1998.
78. Stacey M. R. W., Barclay K., Asai T., et al., Effects of magnesium sulphate on suxamethonium-induced complications during rapid-sequence induction of anaesthesia, ANAESTHESIA, 50, 933-936, 1995.
79. Gaiser R. R., Seem E. H., The use of rocuronium in a pregnant patient with an open eye injury, receiving magnesium medication, for preterm labour, BR. J. ANAESTH., 77, 669-671, 1996.
80. James M. F., Use of rocuronium in a pregnant patient receiving magnesium medication, BR. J. ANAESTH., 78, 772, 1997.
81. Fuchs-Buder T., Wilder-Smith O. H., Borgeat A., et al., Interaction of magnesium sulphate with vecuronium-induced neuromuscular block, BR. J. ANAESTH., 74, 405-409, 1995.
82. Kussman B., Shorten G., Uppington J., et al., Administration of magnesium sulphate before rocuronium : effects on speed of onset and duration of neuromuscular block, BR. J. ANAESTH., 79, 122-124, 1997.
83. Griffin D., Fairman N., Coursin D., et al., Acute myopathy during treatment of status asthmaticus with corticosteroids and steroidal muscle relaxants, CHEST, 102, 510-514, 1992.
84. Buck M. L., Reed M. D., Use of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients, CLIN. PHARM., 10, 32-48, 1991.
85. Cody M. W., Dormon F. M., Recurarization after vecuronium in a patient with renal failure, ANAESTHESIA, 42, 993-995, 1987.
86. Branney S. W., Haenel J. B., Moore F. A., et al., Prolonged paralysis with atracurium infusion : a case report, CRIT. CARE MED., 22, 1699-1701, 1994.
87. Martyn J. A., White D. A., Gronert G. A., et al., Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers, ANESTHESIOLOGY, 76, 822-843, 1992.
88. Sharpe M. D., The use of muscle relaxants in the intensive care unit, CAN. J. ANAESTH., 39, 949-962, 1992.
89. Elliot J. M., Bion J. F., The use of neuromuscular blocking drugs in intensive care practice, ACTA ANAESTHESIOL. SCAND., 106, S70-82, 1995.
90. Booij L. H., The use of muscle relaxants in the intensive care unit, ACTA ANAESTHESIOL. BELG., 48, 35-44, 1997.
91. Darrah W. C., Johnston J. R., Mirakhur R. K., Vecuronium infusions for prolonged muscle relaxation in the intensive care unit, CRIT. CARE MED., 17, 1297-1300, 1989.
92. Khuenl-Brady K. S., Reitstatter B., Schlager A, et al., Long-term administration of pancuronium and pipecuronium in the Intensive Care Unit, ANESTH. ANALG., 78, 1082-1086, 1994.
93. Chung F., Cancer, chemotherapy and anaesthesia, CAN. J. ANAESTH., 29, 364-371, 1982.
94. Eisenkraft J. B., Book W. J., Mann S. M., et al., Resistance to succinylcholine in myasthenia gravis : a dose-response study, ANESTHESIOLOGY, 69, 760-763, 1988.
95. Smith C. E., Donati F., Bevan D. R., Cumulative dose-response curves for atracurium in patients with myasthenia gravis, CAN. J. ANAESTH., 36, 402-406, 1989.
96. Nilsson E., Meretoja O. A., Vecuronium dose-response and maintenance requirements in patients with myasthenia gravis, ANESTHESIOLOGY, 73, 28-32, 1990.
97. Schulte-Sasse U., Eberlein H. J., Schmucker I., et al., Should the use of succinylcholine in pediatric anesthesia be re-evaluated ?, ANAESTHESIOL. REANIM., 18, 13-19, 1993.
98. Azar I., The response of patients with neuromuscular disorders to muscle relaxants : a review, ANESTHESIOLOGY, 61, 173-1, 1984.